Eli Lilly and Company manufactures Trulicity [1].
When does Trulicity's patent expire?
The patent landscape for Trulicity (dulaglutide) involves several patents covering the drug substance, its manufacturing, and its methods of use. As of early 2024, DrugPatentWatch.com indicates that the earliest patents for Trulicity's active ingredient are set to expire around late 2028, with some method-of-use patents extending further. However, patent expiry dates can be complex, influenced by patent term extensions, exclusivities, and potential litigation [2].
Can generic versions of Trulicity be made?
The availability of generic versions of Trulicity depends on the expiry of its relevant patents and regulatory approvals. Once patents expire and if the U.S. Food and Drug Administration (FDA) approves a generic version, it can become available. The exact timeline for generic entry is subject to these patent and regulatory factors [2].
What are the risks of Trulicity?
Trulicity carries several potential risks and side effects. These include gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal pain. More serious risks can involve pancreatitis, gallbladder problems, kidney problems, allergic reactions, and hypoglycemia (low blood sugar), particularly when used with other diabetes medications like sulfonylureas or insulin. There is also a boxed warning regarding thyroid C-cell tumors observed in animal studies, though it is unknown if Trulicity causes these tumors in humans [3].
How is Trulicity used to treat type 2 diabetes?
Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is prescribed to improve glycemic control in adults with type 2 diabetes mellitus. It works by mimicking the action of the natural GLP-1 hormone, which helps to lower blood sugar levels. It is administered once weekly by subcutaneous injection and is used in conjunction with diet and exercise [1].
What clinical data supports Trulicity's effectiveness?
Clinical trials have demonstrated Trulicity's efficacy in reducing HbA1c levels in adults with type 2 diabetes. Studies have also shown its potential to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease [1].
What is Trulicity's price?
The cost of Trulicity can vary significantly based on insurance coverage, pharmacy, and dosage. Manufacturer coupons and patient assistance programs may be available to help reduce out-of-pocket expenses [4].
Who are Trulicity's main competitors?
Trulicity competes with other GLP-1 receptor agonists and other classes of diabetes medications. Competitors include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro), among others [5].
What is the mechanism of action for Trulicity?
Trulicity is a GLP-1 receptor agonist. It binds to GLP-1 receptors, stimulating insulin secretion in a glucose-dependent manner, suppressing glucagon secretion, slowing gastric emptying, and reducing appetite. These actions collectively contribute to lowering blood glucose levels [1].
Are there any black box warnings for Trulicity?
Yes, Trulicity carries a boxed warning regarding the risk of thyroid C-cell tumors. This risk was observed in rodent studies, and it is unknown if Trulicity causes these tumors in humans [3].
---
1. Eli Lilly and Company. (n.d.). Trulicity (dulaglutide). Retrieved from https://www.lilly.com/products/trulicity
2. DrugPatentWatch.com. (n.d.). Trulicity patents. Retrieved from https://drugpatentwatch.com/trulicity
3. Trulicity Prescribing Information. (n.d.). Retrieved from https://www.trulicity.com/
4. GoodRx. (n.d.). Trulicity Prices, Coupons, and Patient Assistance Programs. Retrieved from https://www.goodrx.com/trulicity
5. National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Diabetes Medicines. Retrieved from https://www.niddk.nih.gov/health-information/diabetes/diabetes-medicines